
CancerFree Biotech is a precision medicine company focused on personalized cancer treatment through its proprietary E.V.A. (Ex Vivo Avatar) platform. The platform uses a patient's blood sample to culture circulating tumor cells into 3D tumor organoids for drug sensitivity testing, enabling personalized and precise cancer drug selection. Their services include NGS gene testing for 519 cancer-related genes, E.V.A. Select for ex vivo drug testing, and CTC tracking for monitoring cancer progression. The company aims to reduce patient suffering and treatment risks by improving drug precision during the critical treatment window. CancerFree Biotech has achieved significant milestones including international accelerator selections, awards, and investment, positioning itself as a leader in personalized oncology diagnostics and treatment support in Taiwan and globally.

CancerFree Biotech is a precision medicine company focused on personalized cancer treatment through its proprietary E.V.A. (Ex Vivo Avatar) platform. The platform uses a patient's blood sample to culture circulating tumor cells into 3D tumor organoids for drug sensitivity testing, enabling personalized and precise cancer drug selection. Their services include NGS gene testing for 519 cancer-related genes, E.V.A. Select for ex vivo drug testing, and CTC tracking for monitoring cancer progression. The company aims to reduce patient suffering and treatment risks by improving drug precision during the critical treatment window. CancerFree Biotech has achieved significant milestones including international accelerator selections, awards, and investment, positioning itself as a leader in personalized oncology diagnostics and treatment support in Taiwan and globally.